Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosa

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue SUPPL. 1, 2008, Pages

  Moir, Donald T ^a   Di, Ming ^a   Moore, Richard A ^b   Schweizer, Herbert P ^c   Woods, Donald E ^b  

^a MICROBIOTIX INC   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Bioluminescence; Burkholderia pseudomallei; Pseudomonas aeruginosa; Reporter; Screen; Target

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CARBENICILLIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENE PRODUCT; GENTAMICIN; METRONIDAZOLE; MSL 063457; MSL 063459; MSL 065544; MSL 078978; MSL 080263; MSL 099452; MSL 099633; MSL 102176; MSL 106918; NITROFURANTOIN; PROTEIN FOLA; PROTEIN FTSQ; PROTEIN GLMU; PROTEIN IPK; PROTEIN LIGA; PROTEIN LPXA; PROTEIN LUXCDABE; PROTEIN SECA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOLUMINESCENCE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; DRUG RESEARCH; DRUG STRUCTURE; ESSENTIAL GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ENGINEERING; GROWTH RATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPERON; ORTHOLOGY; PHOTORHABDUS LUMINESCENS; PLASMID; PSEUDOMONAS AERUGINOSA;

BURKHOLDERIA PSEUDOMALLEI; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPERON; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS, DNA;

BURKHOLDERIA PSEUDOMALLEI; LIGA; PHOTORHABDUS LUMINESCENS; PSEUDOMONAS AERUGINOSA;

EID: 58049155242     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(08)70033-6     Document Type: Article

References (46)

1. Currie B.J., Fisher D.A., Howard D.M., Burrow J.N., Selvanayagam S., Snelling P.L., et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74 (2000) 121-127
2. White N.J., Dance D.A., Chaowagul W., Wattanagoon Y., Wuthiekanun V., and Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 2 (1989) 697-701
3. Brett P.J., and Woods D.E. Pathogenesis of and immunity to melioidosis. Acta Trop 74 (2000) 201-210
4. Gilligan P.H., and Whittier S. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, and Acidovorax. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of clinical microbiology. 7th ed. (1999), ASM Press, Washington, DC 526-538
5. Jenney A.W., Lum G., Fisher D.A., and Currie B.J. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 17 (2001) 109-113
6. Piliouras P., Ulett G.C., Ashhurst-Smith C., Hirst R.G., and Norton R.E. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. Int J Antimicrob Agents 19 (2002) 427-429
7. Vorachit M., Chongtrakool P., Arkomsean S., and Boonsong S. Antimicrobial resistance in Burkholderia pseudomallei. Acta Trop 74 (2000) 139-144
8. Wiedemann B., and Grimm H. Susceptibility to Antibiotics: Species Incidence and Trends. In: Lorian V. (Ed). Antibiotics in laboratory medicine (1991), Williams & Wilkins, Baltimore
9. Burtnick M.N., and Woods D.E. Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother 43 (1999) 2648-2656
10. Chan Y.Y., Tan T.M., Ong Y.M., and Chua K.L. BpeAB-Opr B, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob Agents Chemother 48 (2004) 1128-1135
11. Moore R.A., DeShazer D., Reckseidler S., Weissman A., and Woods D.E. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 43 (1999) 465-470
12. Moir D.T., Di M., Opperman T., Schweizer H.P., and Bowlin T.L. A high-throughput, homogeneous, bioluminescent assay for Pseudomonas aeruginosa gyrase inhibitors and other DNA-damaging agents. J Biomol Screen 12 (2007) 855-864
13. de Lorenzo V., and Timmis K.N. Analysis and construction of stable phenotypes in Gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol 235 (1994) 386-405
14. Vogel H.J., and Bonner D.M. Acetylornithinase of Escherichia coli: partial purification and some properties. J Biol Chem 218 (1956) 97-106
15. Hoang T.T., Kutchma A.J., Becher A., and Schweizer H.P. Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43 (2000) 59-72
16. Choi K.H., and Schweizer H.P. An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 5 (2005) 30
17. Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J., et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406 (2000) 959-964
18. Holden M.T., Titball R.W., Peacock S.J., Cerdeno-Tarraga A.M., Atkins T., Crossman L.C., et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 101 (2004) 14240-14245
19. Wolfgang M.C., Lee V.T., Gilmore M.E., and Lory S. Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev Cell 4 (2003) 253-263
20. Moore R.A., Reckseidler-Zenteno S., Kim H., Nierman W., Yu Y., Tuanyok A., et al. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect Immun 72 (2004) 4172-4187
21. de Lorenzo V., Eltis L., Kessler B., and Timmis K.N. Analysis of Pseudomonas gene products using laclq/Ptrp-lac plasmids and transposons that confer conditional phenotypes. Gene 123 (1993) 17-24
22. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4 (1999) 67-73
23. Gerdes S.Y., Scholle M.D., Campbell J.W., Balazsi G., Ravasz E., Daugherty M.D., et al. Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol 185 (2003) 5673-5684
24. Gerdes S.Y., Scholle M.D., D'Souza M., Bernal A., Baev M.V., Farrell M., et al. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J Bacteriol 184 (2002) 4555-4572
25. Jacobs M.A., Alwood A., Thaipisuttikul I., Spencer D., Haugen E., Ernst S., et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100 (2003) 14339-14344
26. Wheeler D.L., Church D.M., Lash A.E., Leipe D.D., Madden T.L., Pontius J.U., et al. Database resources of the National Center for Biotechnology Information: 2002 update. Nucleic Acids Res 30 (2002) 13-16
27. Palma M., DeLuca D., Worgall S., and Quadri L.E. Transcriptome analysis of the response of Pseudomonas aeruginosa to hydrogen peroxide. J Bacteriol 186 (2004) 248-252
28. Firoved A.M., Wood S.R., Ornatowski W., Deretic V., and Timmins G.S. Microarray analysis and functional characterization of the nitrosative stress response in nonmucoid and mucoid Pseudomonas aeruginosa. J Bacteriol 186 (2004) 4046-4050
29. Bagge N., Schuster M., Hentzer M., Ciofu O., Givskov M., Greenberg E.P., et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 48 (2004) 1175-1187
30. Ochsner U.A., Wilderman P.J., Vasil A.I., and Vasil M.L. GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes. Mol Microbiol 45 (2002) 1277-1287
31. Palma M., Worgall S., and Quadri L.E. Transcriptome analysis of the Pseudomonas aeruginosa response to iron. Arch Microbiol 180 (2003) 374-379
32. Wagner V.E., Gillis R.J., and Iglewski B.H. Transcriptome analysis of quorum-sensing regulation and virulence factor expression in Pseudomonas aeruginosa. Vaccine 22 Suppl 1 (2004) S15-S20
33. Whiteley M., Bangera M.G., Bumgarner R.E., Parsek M.R., Teitzel G.M., Lory S., et al. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413 (2001) 860-864
34. Brazas M.D., and Hancock R.E. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49 (2005) 3222-3227
35. Cirz R.T., O'Neill B.M., Hammond J.A., Head S.R., and Romesberg F.E. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol 188 (2006) 7101-7110
36. Neu H.C. Chemical evolution of the fluoroquinolone antimicrobial agents. Am J Med 87 (1989) 2S-9S
37. Goodwin A., Kersulyte D., Sisson G., Veldhuyzen van Zanten S.J., Berg D.E., and Hoffman P.S. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol 28 (1998) 383-393
38. Matsui H., Sano Y., Ishihara H., and Shinomiya T. Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J Bacteriol 175 (1993) 1257-1263
39. Freiberg C., Fischer H.P., and Brunner N.A. Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants. Antimicrob Agents Chemother 49 (2005) 749-759
40. Hutter B., Fischer C., Jacobi A., Schaab C., and Loferer H. Panel of Bacillus subtilis reporter strains indicative of various modes of action. Antimicrob Agents Chemother 48 (2004) 2588-2594
41. Weigel C., Schmidt A., Seitz H., Tungler D., Welzeck M., and Messer W. The N-terminus promotes oligomerization of the Escherichia coli initiator protein DnaA. Mol Microbiol 34 (1999) 53-66
42. Paradis-Bleau C., Sanschagrin F., and Levesque R.C. Peptide inhibitors of the essential cell division protein FtsA. Protein Eng Des Sel 18 (2005) 85-91
43. Korycka-Machala M., Rychta E., Brzostek A., Sayer H.R., Rumijowska-Galewicz A., Bowater R.P., et al. Evaluation of NAD(+)-dependent DNA ligase of mycobacteria as a potential target for antibiotics. Antimicrob Agents Chemother 51 (2007) 2888-2897
44. Payne D.J., Gwynn M.N., Holmes D.J., and Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6 (2007) 29-40
45. Lee J.K., Lee Y.S., Park Y.K., and Kim B.S. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 25 (2005) 290-295
46. Oh H., Stenhoff J., Jalal S., and Wretlind B. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist 9 (2003) 323-328